Related Experiment Videos
Mortality in Crohn's disease
Insights
Young patients with Crohn's disease (a chronic inflammatory bowel disease) face a significantly higher mortality risk, especially within the first few years of diagnosis or after 13 years. Case fatality rates remain unchanged despite treatment advancements.
Area of Science:
- Gastroenterology
- Epidemiology
- Clinical Medicine
Background:
- Crohn's disease is a chronic inflammatory condition affecting the digestive tract.
- Understanding long-term mortality trends is crucial for patient management and healthcare planning.
Purpose of the Study:
- To investigate the mortality patterns and risk factors associated with Crohn's disease in a defined population over a long period.
- To assess changes in case fatality rates over time.
Main Methods:
- Retrospective cohort study of 219 Crohn's disease patients diagnosed in Cardiff between 1934 and 1976.
- Analysis of mortality data and standardized mortality ratios (SMR).
- Examination of risk factors including age at diagnosis and disease duration.
Main Results:
- A total of 40 deaths occurred among the 219 identified patients.
- Patients diagnosed under 20 years old had an SMR of 11, indicating a significantly elevated mortality risk.
- Increased mortality risk was observed within 2.5 years post-diagnosis and after 13 years of disease duration.
- Case fatality rates did not decrease over the 40-year study period.
Conclusions:
- Early-onset Crohn's disease is associated with substantially higher mortality.
- The disease poses a sustained risk, with peaks at specific disease durations.
- Despite therapeutic advancements, the case fatality of Crohn's disease has not improved over recent decades.
Abstract:
Two hundred and nineteen Cardiff residents were identified with Crohn's disease between 1934 and 1976, during which period 40 of them died. Young patients diagnosed under the age of 20 years had a significantly raised standardized mortality rate (SMR) which was 11. The risk of death was particularly high during the first two and a half years after diagnosis and again after the disease had been present for more than about 13 years. Case fatality has not diminished during the last 40 years despite changes in treatment.